Patent ID: 11891389
Assignee: MYOFORTE THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 18:
19. The compound of claim 1, or a pharmaceutically acceptable salt thereof, wherein:
R1 is selected from C6-10aryl and 5- to 10-membered heteroaryl, substituted with a substituent independently selected from halo, —NR6R7, —OR8, —C(O)R8, —C(O)OR8, —C(O)NR6R7, —SOR9, —SO2R9, —SO2NR6R7, —NR10C(O)R8, —NR10C(O)NR6R7, —NR10SO2R8, —NR10SO2NR6R7, C1-6alkyl, C1-6haloalkyl, C3-10cycloalkyl, and 5- to 10-membered heteroaryl;
R2 and R3 are taken together to form oxo;
each R4 is independently selected from halo, C1-6alkyl, and C1-6haloalkyl; and
n is 3, m is 0, 1, or 2, and p is 0.